Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Teva Pharmaceutical Industries Limited American Depositary Shares (NY:TEVA)

16.06 -0.25 (-1.53%)
Official Closing Price Updated: 7:00 PM EDT, Jul 18, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Teva Pharmaceutical Industries Limited American Depositary Shares

< Previous 1 2 3 4 5 6 7 8 9
...
20 21 Next >
Billionaire Stanley Druckenmiller Sold His Entire Stake in Palantir and Has Loaded Up on These 2 Exceptional Stocks for 3 Consecutive Quarters
Duquesne Family Office's billionaire chief dumped his fund's stake in Wall Street's artificial intelligence (AI) darling in favor of two reasonably cheap stocks that have taken off in recent years. 
Via The Motley Fool
Topics Artificial Intelligence
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Looking Into Teva Pharmaceutical Indus's Recent Short Interest
Via Benzinga
What Analysts Are Saying About Teva Pharmaceutical Indus Stock
Via Benzinga
Billionaire Stanley Druckenmiller Loaded Up on These 3 Stocks. Are They Buys?
Via The Motley Fool
How Do Investors Really Feel About Teva Pharmaceutical Indus?
Via Benzinga
Where Teva Pharmaceutical Indus Stands With Analysts
Via Benzinga
Billionaire Stanley Druckenmiller Dumped His Entire Stake in Palantir and Has Piled Into This Suddenly Unstoppable Drug Stock for 3 Straight Quarters
Duquesne Family Office's billionaire chief sold every share of Wall Street's hottest artificial intelligence (AI) stock in favor of a drugmaker whose shares have surged 142% in two years. 
Via The Motley Fool
Topics Artificial Intelligence Economy
Goldman Sachs Bullish On Branded Drug Upside At Teva: What About Viatris?
Goldman Sachs initiates Teva, Viatris, and Amneal, highlighting branded growth and pipeline strength, but one company's unclear outlook. 
Via Benzinga
9 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Teva Reaffirms Growth Strategy, Eyes $5 Billion Innovative Franchise By 2030
Teva outlines its accelerated growth strategy focused on innovation, aiming for $5 billion in biopharma revenue by 2030, while maintaining a strong generics and biosimilars base. 
Via Benzinga
Earnings Scheduled For May 7, 2025
Via Benzinga
Forecasting The Future: 6 Analyst Projections For Teva Pharmaceutical Indus
Via Benzinga
Billionaire Stanley Druckenmiller Just Sold One of Wall Street's Hottest Stock-Split Stocks and Is Piling Into a Promising Drugmaker Instead
Duquesne Family Office's chief dumped his entire stake in one of Wall Street's premier stock-split stocks and has continued to load up on a super-cheap drug company for a third straight quarter. 
Via The Motley Fool
Topics Artificial Intelligence Economy Government
Why Is Teva Stock Trading Higher On Tuesday?
Teva starts IND-enabling studies for BD9, a dual-target therapy for asthma and atopic dermatitis, under license from Biolojic Design. 
Via Benzinga
Why Teva Pharmaceuticals Stock Blasted 6% Higher Today
Via The Motley Fool
Marriott International To Rally More Than 17%? Here Are 10 Top Analyst Forecasts For Monday
Via Benzinga
This Wayfair Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday
Via Benzinga
Why Teva Pharmaceutical Stock Is Soaring Today
Via The Motley Fool
Topics Earnings Stocks
Teva Shares Climb On Profit Beat, $700 Million Cost Plan, Biopharma Pivot Momentum
Teva beat Q1 EPS estimates and raised 2025 profit guidance as Austedo sales soared and margins improved, despite missing revenue expectations. 
Via Benzinga
Teva Surges On Profit Guidance Boost Despite A Mixed First-Quarter Report
Teva stock jumped early Wednesday after the drugmaker hiked its 2025 profit outlook, though trimmed its sales forecast. 
Via Investor's Business Daily
Topics Government
Neurocrine Biosciences' Ingrezza Q1 Sales Prove Resilient, Analysts Boost Price Target
Neurocrine stock gains as Q1 EPS beats estimates; Ingrezza sales climb 8% YoY with record new patients and strong analyst price target hikes. 
Via Benzinga
Why Is Israel-Based Generic Drug Focused Teva Pharmaceutical Stock Trading Higher On Monday?
FDA approves Teva and Alvotech's Selarsdi as an interchangeable biosimilar to Stelara, supporting the treatment of multiple chronic inflammatory diseases. 
Via Benzinga
What Does the Market Think About Teva Pharmaceutical Indus?
Via Benzinga
Trump Tariff Sell-Off: 3 Superb Stocks That Make for No-Brainer Buys Right Now
Short-term uncertainty has led to a golden opportunity for long-term investors. 
Via The Motley Fool
Topics Economy Government Stocks
5 of the Safest Stocks Billionaire Money Managers Bought Ahead of Wall Street's Historic Volatility
Some of Wall Street's most-prominent asset managers were scooping up shares of time-tested businesses before the stock market meltdown. 
Via The Motley Fool
Topics Government Stocks World Trade
Dow Jones, S&P 500 Pharma Names Slammed As New Trump Tariffs Target Drug Imports
Big pharmaceutical names plowed lower Wednesday after Trump on Tuesday said that tariffs would take aim at drug imports. 
Via Investor's Business Daily
Topics Government Stocks World Trade
These Are My 3 Worst-Performing Stocks So Far in 2025 -- and the One I'm Buying More of Now
Via The Motley Fool
Billionaire Stanley Druckenmiller Jettisoned Shares of Palantir and Nvidia, and Is Piling Into 3 High-Profile Turnaround Stocks
Duquesne Family Office's chief is dumping shares of Wall Street's hottest artificial intelligence (AI) stocks in favor of a trio of companies that are righting their respective ships. 
Via The Motley Fool
Topics Artificial Intelligence
Here Are Billionaire Stanley Druckenmiller's 5 Biggest Stock Holdings
Via The Motley Fool
< Previous 1 2 3 4 5 6 7 8 9
...
20 21 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback